Canada’s Pharmaceutical Products Industry: Canadian Industrial Profile Winter2009

Default product image

Canada’s Pharmaceutical Products Industry: Canadian Industrial Profile Winter2009

Industry Economic Analysis

Author: Signal49 Research

$550.00

  • U.S. Recession—Although health-care spending is defensive, uninsured and unemployed people will spend less on drugs. With half of production destined for the U.S., the industry will be affected.
  • Price Controls—Medications that are still under patent protection are subject to price controls in Canada. This has contributed to surging exports to the U.S.— but has also limited price and profit growth.
  • Aging Population—People spend more on pharmaceutical products as they age. Thus, as the average age of the population increases, so does per capita spending on drugs.
Want a discount? Become a member by purchasing a subscription! Learn More

This industry profile provides a five-year forecast for Canada’s Pharmaceutical Products Industry.

Questions?

Call 1-888-801-8818 or send us a message (Mon–Fri: 8 am to 5 pm).

This field is hidden when viewing the form
This field is hidden when viewing the form

Require an accessible version of this research?

Upon request, Signal49 Research offers accessible versions of research. Please contact us to request your accessible version.

Learn more about our accessibility policies.